Sarepta Therapeutics (SRPT) Gains on Coverage Update

October 12, 2016 10:36 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Sarepta Therapeutics (NASDAQ: SRPT) active as Anthem is said to be out positive now on Etep coverage.

Link (doc)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Trader Talk

Add Your Comment